SMS Pharmaceuticals Limited — Others, 28-12-2024: Trading Window

SMS Pharmaceuticals has announced a board meeting to discuss the financial results for the third quarter ended 31st December 2024. In line with its compliance protocols, the trading window for the company's shares will be closed from 1st January 2025 until 48 hours after the results are declared.

This closure serves to uphold the integrity of trading and safeguard against insider trading, which may impact investor confidence. The upcoming results could provide insights into the company's performance, presenting potential opportunities or risks for investors as they reflect on the ongoing strategic direction of SMS Pharmaceuticals.